- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2020-004200-33.
Displaying page 1 of 1.
| EudraCT Number: 2020-004200-33 | Sponsor Protocol Number: CEGA230B2404 | Start Date*: 2026-06-05 | |||||||||||
| Sponsor Name:Novartis Pharma AG | |||||||||||||
| Full Title: A Phase IV, multi-center, open-label study to determine the safety, tolerability and clinical outcomes following oral administration of EGATEN™ (Triclabendazole) in patients (6 years of age or o... | |||||||||||||
| Medical condition: Fascioliasis | |||||||||||||
|
|||||||||||||
| Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: Outside EU/EEA | |||||||||||||
| Trial results: (No results available) | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.